Vimarsana
Biggest News Aggregation in the World

Page 25 - Breakthrough Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Devices Program Today - Breaking & Trending Today

Selux Diagnostics Awarded $2.8 Million Grant from NIH for Commercialization of its NGP Platform - Vimarsana News

Selux Diagnostics Awarded $2.8 Million Grant from NIH for Commercialization of its NGP Platform

/PRNewswire/ -- Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance,...

CMS Proposal Would Impact Coverage Of Innovative Digital Health Technologies - Food, Drugs, Healthcare, Life Sciences - Vimarsana News

CMS Proposal Would Impact Coverage Of Innovative Digital Health Technologies - Food, Drugs, Healthcare, Life Sciences

The MCIT/RN Rule was intended to address concerns that delay or uncertainty around Medicare coverage hampered beneficiary access to innovative technologies.

Source: mondaq.com
Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated "Breakthrough Devices" | Nelson Mullins Riley & Scarborough LLP - Vimarsana News

Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated "Breakthrough Devices" | Nelson Mullins Riley & Scarborough LLP

On September 15, 2021, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) published a proposed rule, which (if finalized) would repeal the Agency’s Medicare Coverage...

CMS Medicare Coverage Pathway for FDA-Designated Breakthrough Devices Repeal Proposed - Vimarsana News

CMS Medicare Coverage Pathway for FDA-Designated Breakthrough Devices Repeal Proposed

Centers for Medicare & Medicaid Services CMS proposed rule would repeal Medicare Coverage of Innovative Technology & Definition of Reasonable and Necessary MCIT/R&N final rule; pathway to provide national Medicare coverage of medical devices designated Breakthrough Devices by Food and Drug Administration FDA

PoNS Device Is a Stroke Rehab Breakthrough, Per FDA - Vimarsana News

PoNS Device Is a Stroke Rehab Breakthrough, Per FDA

Helius Medical Technologies Inc has received Breakthrough Designation from the US Food and Drug Administration for its PoNS device as a temporary treatment of dynamic gait and balance deficits due to symptoms from stroke, it announces.